Online Submissions
Already have a Username/Password for Rare Diseases and Orphan Drugs?
Go to Login
Need a Username/Password?
Go to Registration
Registration and login are required to submit items online and to check the status of current submissions.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
- Where available, URLs for the references have been provided.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
- The corresponding author is clearly indicated. His/her contact details are correctly mentioned.
- All required statements and declarations have been provided.
- The abstract is up to 290 words.
Copyright Notice
In submitting this article to Rare Diseases and Orphan Drugs. An International Journal of Public Health author certifies that:
- the article is original, not in the public domain and has not been published in any other journal or book, is not being considered for publication elsewhere in any form and will not be submitted for such consideration while under review by this journal;
- he/she is they are the sole author(s) and proprietor(s) of the article and have full power to enter into this agreement and in granting rights to the Istituto Superiore di Sanità are not in breach of any other obligation;
- nothing in the article is obscene, defamatory, libelous, or otherwise unlawful, violates any right of privacy or infringes any intellectual property rights (including without limitation copyright, patent, or trademark) or other rights of any kind of any person or entity;
- nothing in the article infringes any duty of confidentiality which the author(s) may owe to another party or violates any contract, express or implied, that the author(s) may have entered into, and all of the institutions where the work, as reflected in the article, was performed have authorized publication;
- to his /hers/theirs-and currently accepted scientific knowledge all statements contained in it purporting to be facts are true and does not contain any material or instructions that might cause harm or injury.
4) and he/she agrees to the following license agreement:
- the article will be published Open Access in the Rare Diseases and Orphan Drugs An International Journal of Public Health (RARE Journal) by the Istituto Superiore di Sanità under the terms of the Creative Commons license Attribution-NonCommercial-NoDerivs 3.0 (http://creativecommons.org/licenses/by-nc-nd/3.0/)
Privacy Statement
Manuscripts will be reviewed with due respect for authors’ confidentiality. Reviewers also have rights to confidentiality, which must be respected by the editor. Confidentiality may have to be breached if dishonesty or fraud is alleged but otherwise must be honored. RARE Journal editors won’t disclose information about manuscripts (including their receipt, content, status in the reviewing process, criticism by reviewers, or ultimate fate) to anyone other than the authors and reviewers. This includes requests to use the materials for legal proceedings.
RARE Journal makes clear to the reviewers that manuscripts sent for review are privileged communications and are the private property of the authors. Therefore, reviewers and members of the editorial staff will respect the authors’ rights by not publicly discussing the authors’ work or appropriating their ideas before the manuscript is published. Reviewers are not allowed to make copies of the manuscript for their files and are prohibited from sharing it with others, except with the editor’s permission. Reviewers destroy copies of manuscripts after submitting reviews. Editors are not keeping copies of rejected manuscripts.
Reviewer comments are not be published without permission of the reviewer, author, and editor.
Identifying information (including names, initials, or hospital numbers) of study participants should not be published under any circumstances. It is the authors’ responsibility to respect the patients’ right of privacy, as well as the national and international legal framework on this issue.